Stroncek, David F.

NAFLD causes selective CD4+ T lymphocyte loss and promotes hepatocarcinogenesis

Ma, C., Kesarwala, A. H., Eggert, T., Medina-Echeverz, J., Kleiner, D. E., Jin, P., Stroncek, D. F., Terabe, M., Kapoor, V., ElGindi, M., et al. (2016) · Nature

Liver Disease Diagnosis and TreatmentCancer, Lipids, and Metabolism

Cited by 766

CD4/CD8 T-cell selection affects chimeric antigen receptor (CAR) T cell potency and toxicity: updated results from a phase I anti-CD22 CAR T cell trial

Shah, N. N., Highfill, S. L., Shalabi, H., Yates, B., Jin, J., Wolters, P. L., Ombrello, A., Steinberg, S. M., Martin, S., Delbrook, C., et al. (2020) · Journal of Clinical Oncology

CAR-T cell therapy researchAcute Lymphoblastic Leukemia research

Cited by 421

Gene expression profiling of cutaneous wound healing

Deonarine, K., Panelli, M. C., Stashower, M. E., Jin, P., Smith, K., Slade, H. B., Norwood, C., Wang, E., Marincola, F. M., & Stroncek, D. F. (2007) · Journal of Translational Medicine

Wound Healing and TreatmentsNonmelanoma Skin Cancer Studies

Cited by 229

Myeloid cells in peripheral blood mononuclear cell concentrates inhibit the expansion of chimeric antigen receptor T cells

Stroncek, D. F., Ren, J., Lee, D. W., Tran, M., Frodigh, S. E., Sabatino, M., Khuu, H., Merchant, M. S., & Mackall, C. L. (2016) · Cytotherapy

CAR-T cell therapy researchImmunotherapy and Immune Responses

Cited by 148

Effect of cryopreservation on autologous chimeric antigen receptor T cell characteristics

Panch, S. R., Srivastava, S. K., Elavia, N., McManus, A., Liu, S., Jin, P., Highfill, S. L., Li, X., Dagur, P., Kochenderfer, J. N., et al. (2019) · Molecular Therapy

CAR-T cell therapy researchImmunotherapy and Immune Responses

Cited by 107

Elutriated lymphocytes for manufacturing chimeric antigen receptor T cells

Stroncek, D. F., Lee, D. W., Ren, J., Sabatino, M., Highfill, S., Khuu, H., Shah, N. N., Kaplan, R. N., Fry, T. J., & Mackall, C. L. (2017) · Journal of Translational Medicine

CAR-T cell therapy researchImmunotherapy and Immune Responses

Cited by 80

HLA class I and II genotype of the NCI-60 cell lines

Adams, S., Robbins, F.-M., Chen, D., Wagage, D., Holbeck, S. L., Morse, H. C., Stroncek, D., & Marincola, F. M. (2005) · Journal of Translational Medicine

Immunotherapy and Immune Responsesvaccines and immunoinformatics approaches

Cited by 68

Human Mesenchymal Stromal Cell (MSC) Characteristics Vary Among Laboratories When Manufactured From the Same Source Material: A Report by the Cellular Therapy Team of the Biomedical Excellence for Safer Transfusion (BEST) Collaborative

Stroncek, D. F., Jin, P., McKenna, D. H., Takanashi, M., Fontaine, M. J., Pati, S., Schäfer, R., Peterson, E., Benedetti, E., & Reems, J.-A. (2020) · Frontiers in Cell and Developmental Biology

Mesenchymal stem cell researchHematopoietic Stem Cell Transplantation

Cited by 59

Effects of starting cellular material composition on chimeric antigen receptor T-cell expansion and characteristics

Elavia, N., Panch, S. R., McManus, A., Bikkani, T., Szymanski, J., Highfill, S. L., Jin, P., Brudno, J., Kochenderfer, J., & Stroncek, D. F. (2019) · Transfusion

CAR-T cell therapy researchT-cell and B-cell Immunology

Cited by 43

Rapid anti-myeloma activity by T cells expressing an anti-BCMA CAR with a human heavy-chain-only antigen-binding domain

Mikkilineni, L., Natrakul, D. A., Lam, N., Manasanch, E. E., Mann, J., Weissler, K. A., Wong, N., Brudno, J. N., Goff, S. L., Yang, J. C., et al. (2024) · Molecular Therapy

CAR-T cell therapy researchMultiple Myeloma Research and Treatments

Cited by 16

Cryopreservation of mesenchymal stem/stromal cells using a DMSO-free solution is comparable to DMSO-containing cryoprotectants: results of an international multicenter PACT/BEST collaborative study

Mamo, T., Cox, C. A., Demorest, C., Fontaine, M. J., Hubel, A., Kelley, L., Khan, A., Marks, D. C., Pati, S., Reems, J.-A., et al. (2024) · Cytotherapy

Mesenchymal stem cell researchHematopoietic Stem Cell Transplantation

Cited by 16

Quality assessment of cellular therapies: the emerging role of molecular assays

Stroncek, D. F., Jin, P., Ren, J., Feng, J., Castiello, L., Civini, S., Wang, E., Marincola, F. M., & Sabatino, M. (2010) · The Korean Journal of Hematology

CAR-T cell therapy researchHematopoietic Stem Cell Transplantation

Cited by 12

Treatment of Patients with T Cells Expressing a Fully-Human Anti-BCMA CAR with a Heavy-Chain Antigen-Recognition Domain Caused High Rates of Sustained Complete Responses and Relatively Mild Toxicity

Mikkilineni, L., Manasanch, E. E., Natrakul, D., Brudno, J. N., Mann, J., Goff, S. L., Yang, J. C., Lam, N., Maric, I., Stetler-Stevenson, M., et al. (2021) · Blood

CAR-T cell therapy researchMultiple Myeloma Research and Treatments

Cited by 9